Type 1 Diabetes Mellitus and Klinefelter Syndrome.

Teruaki Sakurai, Katsumi Iizuka, Takehiro Kato, Jun Takeda

Open access · diamondAbstract readCase Reports

In one paragraph

Article in Internal medicine (Tokyo, Japan), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.2field-weighted citation impact, top 44% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

Asian journal of andrology
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Teruaki SakuraiDepartment of Diabetes and Endocrinology, Graduate School of Medicine, Gifu University, Japan.

Katsumi IizukaDepartment of Diabetes and Endocrinology, Graduate School of Medicine, Gifu University, Japan.

Takehiro KatoDepartment of Diabetes and Endocrinology, Graduate School of Medicine, Gifu University, Japan.

Jun TakedaDepartment of Diabetes and Endocrinology, Graduate School of Medicine, Gifu University, Japan.

Gifu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 60-year-old male patient with type 1 diabetes mellitus (T1DM) was admitted for glycemic control. The patient exhibited abdominal adiposity, osteoporosis, and high insulin requirement (>100 U), and we suspected hypogonadism. A physical examination revealed small testes and thin pubic hair, laboratory examination found high luteinizing hormone (LH) and follicle stimulating hormone (FSH) levels and low testosterone levels, and a chromosome analysis (47, XXY) indicated hypogonadism due to Klinefelter syndrome (KS). KS is associated with autoimmune diseases and patients positive for diabetes related auto-antibodies. In male patients with T1DM and abdominal adiposity, the concurrence of KS should be taken into consideration.

Indexed as

Diabetes Mellitus, Type 1Follicle Stimulating HormoneHumansHypoglycemic AgentsHypogonadismInsulinKlinefelter SyndromeLuteinizing HormoneMaleMiddle AgedObesity, AbdominalOsteoporosisTestosteroneFollicle Stimulating HormoneHypoglycemic AgentsInsulinLuteinizing HormoneTestosteroneabdominal adiposityKlinefelter syndrome (KS)osteoporosistype 1 diabetes mellitus (T1DM)

Identifiers

PMID30146555

DOI10.2169/internalmedicine.1051-18

PMCPMC6378147

OpenAlexW2888522066

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.